Comparing Ingevity (NGVT) and Its Peers

Ingevity (NYSE: NGVT) is one of 31 public companies in the “Commodity Chemicals” industry, but how does it compare to its rivals? We will compare Ingevity to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, earnings and risk.

Risk & Volatility

Ingevity has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s rivals have a beta of 1.15, meaning that their average stock price is 15% more volatile than the S&P 500.

Institutional & Insider Ownership

91.4% of Ingevity shares are owned by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 0.1% of Ingevity shares are owned by insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


This table compares Ingevity and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.50% 24.34% 5.63%

Earnings and Valuation

This table compares Ingevity and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 34.87
Ingevity Competitors $4.01 billion $340.26 million 139.29

Ingevity’s rivals have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Ingevity and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 6 0 3.00
Ingevity Competitors 106 820 1222 36 2.54

Ingevity presently has a consensus price target of $76.00, indicating a potential downside of 1.83%. As a group, “Commodity Chemicals” companies have a potential downside of 0.41%. Given Ingevity’s rivals higher probable upside, analysts plainly believe Ingevity has less favorable growth aspects than its rivals.


Ingevity beats its rivals on 7 of the 13 factors compared.

Ingevity Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Ratings for Ingevity Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corporation and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply